Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
103.00
7.70 (8.08%)
At close: May 29, 2025, 3:59 PM
103.33
0.32%
After-hours: May 29, 2025, 07:38 PM EDT
Blueprint Medicines Revenue
Blueprint Medicines reported an annual revenue of $508.82M, reflecting a 104.04% growth. For the quarter ending March 31, 2025, Blueprint Medicines generated $149.41M in revenue.
Revenue (ttm)
$508.82M
Revenue Growth
104.04%
Price / Sales Ratio
10.77
Revenue / Employee
$746.08K
Employees
682
Market Cap
6.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|